Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu, 702-210, South Korea.
Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, 702-210, South Korea.
Small. 2016 Sep;12(35):4894-4901. doi: 10.1002/smll.201601721. Epub 2016 Jul 21.
New imaging probes with high sensitivity and stability are urgently needed to accurately detect sentinel lymph nodes (SLNs) for successful cancer diagnosis. Herein, the use of highly sensitive and stable PEGylated radionuclide-embedded gold nanoparticles (PEG-RIe-AuNPs) is reported for the detection of SLNs by combined positron emission tomography and Cerenkov luminescence imaging (PET/CLI). PEG-RIe-AuNPs show high sensitivity and stability both in vitro and in vivo, and are not toxic to normal ovarian and immune cells. In vivo PET/CLI imaging clearly reveals SLNs as early as 1 h post PEG-RIe-AuNP-injection, with peak signals achieved at 6 h postinjection, which is consistent with the biodistribution results. Taken together, the data provide strong evidence that PEG-RIe-AuNPs are promising as potential lymphatic tracers in biomedical imaging for pre and intraoperative surgical guidance.
需要具有高灵敏度和稳定性的新型成像探针来准确检测前哨淋巴结 (SLN),以实现成功的癌症诊断。在此,我们报告了使用高灵敏度和稳定的聚乙二醇化放射性核素嵌入金纳米粒子 (PEG-RIe-AuNPs) 通过正电子发射断层扫描和切伦科夫发光成像 (PET/CLI) 来检测 SLN。PEG-RIe-AuNPs 在体外和体内均表现出高灵敏度和稳定性,对正常卵巢和免疫细胞没有毒性。体内 PET/CLI 成像在注射 PEG-RIe-AuNP 后 1 h 即可清晰显示 SLN,在注射后 6 h 达到峰值信号,与生物分布结果一致。综上所述,这些数据为 PEG-RIe-AuNPs 作为生物医学成像中潜在的淋巴示踪剂用于术前和术中手术引导提供了有力证据。